In addition to the results from SURPASS 4, which was designed to provide preliminary evidence for the cardiovascular safety of tirzepatide, a separate analysis pooling all the clinical trials with tirzepatide was used to generate a pre-specified estimate of cardiovascular events [20] (Table 1)
You never see units
Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: Relationships with postprandial glycemic and insulinemic responses
Each schedule, whether for Ozempic, Wegovy, or Rybelsus, emerged from dose-finding studies that tested multiple regimens
This protocol establishes standardized methodologies for evaluating this compound's bioactivity in cellular models relevant to atherosclerosis progression, particularly monocyte adhesion , macrophage foam cell formation , and endothelial dysfunction [1] [2]
Trial populations, comorbidities, and endpoints varied across the studies, and individual results differ